Sources say Stephen Miller and MAHA allies sank Heidi Overton’s FDA nomination, leaving the agency facing up to two years ...
Novo revamps NovoCare app offering Wegovy without membership fees, adding fitness and meal partnerships. CEO Mike Doustdar ...
Hims & Hers launches peptides like sermorelin, NAD+, glutathione, B12, and L-carnitine for wellness. BPC-157 and TB-500 ...
Endpoints News caught up with a handful of life science companies on the sidelines of the Jefferies Global Healthcare ...
Pfizer pays Chinese biotech Starna $330M upfront for three in vivo CAR-T autoimmune programs, with up to $2.3B in milestones.
Merck scraps nemtabrutinib after a DMC flags risk-benefit concerns in Ph3 CLL study, ending the BTK drug behind its $2.7B ...
Lilly's mevidalen failed Phase 2 in Alzheimer's patients, missing iADRS improvement goals. No further development planned for the dopamine D1 receptor drug.
Cognito Therapeutics' Spectris device showed mixed Alzheimer's results; failed primary endpoints but slowed decline 56% in ...
White House drops Heidi Overton’s FDA nomination amid thin Senate support, leaving a narrow window to name a replacement.
Priavoid’s oral amyloid oligomer drug PRI-002 misses primary endpoint in 300-person Ph2 Alzheimer’s study; next steps ...
Demis Hassabis' Isomorphic Labs has raised a record $5 billion Series C round. Here are 3 takeaways on what comes next.
Marrow Therapeutics raised $173M to develop siRNA drug MAR-101 for sickle cell disease, as gene therapies Casgevy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results